middle.news
Rhythm Biosciences Advances ColoSTAT® Beta Kit to Final Pre-Commercial Phase
1:44am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Rhythm Biosciences Advances ColoSTAT® Beta Kit to Final Pre-Commercial Phase
1:44am on Monday 2nd of June, 2025 AEST
Key Points
Successful verification and validation of ColoSTAT® Beta assay
Over 96% of tests met performance targets for commercial use
Improved assay precision, reliability, and reduced turnaround times
Transition to final manufacturing phase with partner Quansys
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Rhythm Biosciences (ASX:RHY)
OPEN ARTICLE